5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
about
Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621Biosimilar, biobetter and next generation therapeutic antibodies6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.Coupling of aggregation and immunogenicity in biotherapeutics: T- and B-cell immune epitopes may contain aggregation-prone regions.Antibody-drug conjugates: present and future.
P2860
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
@en
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
@nl
type
label
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
@en
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
@nl
prefLabel
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
@en
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
@nl
P2860
P356
P1476
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
@en
P2093
Alain Beck
Thierry Wurch
P2860
P304
P356
10.4161/MABS.2.2.11302
P577
2010-03-01T00:00:00Z